Thinking on Ethics and Science Principle in Clinical Drug Trials

Xiao-feng GUO,Jing-ping ZHAO,Jin-dong CHEN

2005-01-01

Abstract:The clinical drug trails should accord to ethics and science principle.The ethics principle requires subjects to be benefited at greatest degree and avoid harm as much as possible.Randomly,double-blind and control methods accord to science principle but challenge ethics.

What problem does this paper attempt to address?

Protection of Human Rights in Clinical Trials

SHAN Wei,CONG Hang-qing

2011-01-01

Abstract:With the growing legal consciousness of nation,the contradiction in the clinical trials appears gradually.Researchers and subjects face many complicated problems.In that case,the clinical investigators and patients should clearly know their rights and obligations.Then,we should propose the practical ways to protect patients.There are three ways:(1) Medical Ethics Committee set up a position and the staff should track every stage of the clinical trial;(2) Regular doctor should provide professional advices to patients and let them know the effect of the clinical trial;(3) Improvement the registry of clinical trials as soon as possible.
Thinking on ethical principle in bioequivalence studies

Wei QIAN,Jin YANG,Lei CHEN,Da-wei XIAO

DOI: https://doi.org/10.3969/j.issn.1009-2501.2007.03.023

2007-01-01

Abstract:The clinical trails should be conducted in accordance with the ethical principles that have their origin in the declaration of Helsinki and that are consistent with GCP. A trial should be initiated and continued only if the anticipated benefits justify the risks. According to the principle, this paper gives some thinking on the ethical principle in bioequivalence study of some special drugs.
On the Ethical Problem in Drug Clinical Trials

JIANG Chun-yan,YANG Guo-bin,ZHENG Jun,WANG Qian,LUO Bing

DOI: https://doi.org/10.3969/j.issn.1001-8565.2011.06.029

2011-01-01

Abstract:This paper mainly discusses a number of ethical issues in drug clinical trials.In China we face some challenges in protecting subjects' rights.In order to protect our subjects more better and get a long-term development of our clinical trials,we need to accelerate the pace of capacity building on improving laws and regulations,improving the level of research,increasing supervision and other aspects of our clinical trials.
Ethical principles for clinical research

Ping Ji,Haiyan Li

DOI: https://doi.org/10.3877/cma.j.issn.2095-3216.2014.01.003

2014-01-01

Abstract:With the widely conduct of clinical research,various players involved in clinical research have realized that it is vital to comply with the ethical guidelines.The present article begins with the introduction of the current internationally recognized ethical principles and the national regulation. In addition,the application of these ethical principles and regulation in the 3 key aspects of ethical review including science,ethics and quality assurance are highlighted.For instance,how to assess the risk/benefit ratio,the appropriate informed consent process,subject recruitment/privacy and confidentiality protection, the requirements of the continuing review,and research registration,publication and dissemination of results.Lastly,the common noncompliance findings in China are discussed.
Development and Problems of Medical Ethics in Clinical Drug Trials

李廷谦,王蕾,王刚

DOI: https://doi.org/10.3969/j.issn.1672-2531.2002.03.003

2002-01-01

Abstract:Medical ethics must be considered for protecting the rights and interests of patients in clinical trials. Now the rights of the subjects are more and more emphasisedi but there are some problems. It is evidence-based medicine(EBM) and emphasis of evidence that need the high-quality clinical trials, yet it violates the principle of ethics in some degree. It will be helpful for the administrators to supervise the clinical trials on drugs well from the point of ethical views.
Main principles of designing clinical trial of drugs

Yang Fu-de

DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.44.054

2006-01-01

Abstract:AIM:To develop clearly the main principles and methods of drug clinical trials.METHODS:A comprehensive medical literature research was performed by computer,and the methods and principles of designing drug clinical trials were introduced combining with the health statistical principle.RESULTS:①Three principles:Control,randomization and replication.②Seven controlled methods:Blank control,placebo control,experimental condition control,standard control,auto-control and cross-over auto-control,before-after control of different cases(historical control),without control study.③Four controlled methods of false positive and false negative mistakes:Precise evaluation of the sample amount and avoid sampling error;Reliable and specific diagnosis standard as well as inclusive and exclusive criteria to select study subjects;Blindness method was used to collect data,and control information bias;Uniform therapeutic project,observing marker and method were confirmed.CONCLUSION:Scientific and strict clinical trials of drugs are helpful to obtain actual and reliable research results.
Development and Problems of Medical Ethics in Foreign Clinical Drug Trials

王蕾,王刚,李廷谦,张瑞明

DOI: https://doi.org/10.3969/j.issn.1007-7669.2003.10.014

2003-01-01

Abstract:Medical ethics must be considered for protecti ng the rights and inte rests of patients in clinical trials. The Declaration of Helsinki has a predomin ant protectionist ethics towards the community and individuals approached to par ticipate in research. Now the subjects have enhanced the level of the rights and interests, but limits of some rights in the declaration are devoid of systemati cness and have ambiguous explanation. The use of placebo controls in clinical tr ials of drugs proved to be an unusually vexing problem. FDA officials consider placebo controls the “gold standard”, nevertheless placebo controls are short of scientific evidence. It is Evidence-based Medicine (EBM) and emphasis of ev idence who need the high-quality clinical trials, yet it violates the principle of ethics in some degree. It will be helpful for the administrators to supervis e the clinical experiments on drugs well from the point of ethical views.
Challenges to Ethics Committee and Investigators of Protecting the Rights of Subjects in Clinical Trials

MAO Yi-min

2010-01-01

Abstract:Ethics Committee is the supervisor and regulator in protecting the rights of subjects,and investigators are those who put something into practice.There are great challenges to Chinese ethics committee and investigators when we confront more and more global trials.Only after ethics committee and investigators boost their ability and improve common problems in clinical trials,then can we safeguard the rights of subjects better.
The Ethical Protection for Participants of Vulnerable Groups in Clinical Trials

江一峰,耿雯倩,祝延红,冯运

DOI: https://doi.org/10.12014/j.issn.1002-0772.2017.06a.07

2017-01-01

Abstract:Social and physiological vulnerable populations in clinical trials include children, pregnant women, mental disorder patients, cognitive impairment patients, terminate patients, prisoners, employees and students.Vulnerable groups may suffer from more risks or injuries than normal subjects.Therefore, it is necessary to provide better protection and safeguards for participants of vulnerable groups, including the sound and justifiable recruitment and assurance of informed consent.Three ethical principles of respect, beneficence and justice should be followed in the protection of participants of vulnerable groups, including informed consent, assessment of risks and benefits, selection of subjects.The relative regulations should be completed and the ethical review standard should be unified.Meanwhile, the rejection of participants of vulnerable groups enrolled in clinical trials should be avoided.
Ethical Principles of Clinical and Translational Research

Ning Lynn Chen,Ban Leong Sng

DOI: https://doi.org/10.1016/j.anclin.2024.01.003

Abstract:There are potential ethical pitfalls when performing clinical and translational research. The growing emphasis on evidence-based medicine and an understanding of basic ethical principles demands attention from the clinician scientist. Underlying principles such as respect for autonomy and considering the risk-benefit profile for each participant should remain the foundation when considering ethical issues in clinical research. Developing technology, the growth of large databases, and unanticipated health crises require ethical guidelines to be dynamic and continuously reviewed to adequately address potential ethical quandaries. Although there are various international guidelines in this area, there remains heterogeneity in their interpretation and application.
Specialty and Related Medical Ethical Issues in Clinical Trials of Anticancer Drugs

ZHANG Lei,HAO Chunyi,LIAO Hongwu,LU Ting,ZHOU Shunlian,LI Jie

DOI: https://doi.org/10.3971/j.issn.1000-8578.2017.16.1559

2017-01-01

Abstract:The research and development of new anticancer drugs rely on high quality clinical trials,which have both common but special characteristics compared with non-anticancer drugs,and their related medical ethical issues are getting more and more attention.This paper discusses and summarizes the specialty of study objects,subjects' recruitment,informed consent,experimental design,observation of therapeutic effect.security evaluation,and related medical ethical issues in clinical trials of anticancer drugs,in order to provide scientific basis and reference for protecting subjects better and get a more standardized long-term development of clinical trials about anticancer drugs.
Good clinical practice, a transparent way of life. A review

A J van Dongen

DOI: https://doi.org/10.1016/s0895-6111(00)00051-3

Abstract:Investigators are regarded as central to the concept of clinical trials. Apart from bearing scientific responsibility, they will be confronted with a great number of ethical dilemma's concerning, amongst others, the justification and design of the trial, subject selection and informed consent, and presentation of the trial results. The ethical principles of biomedical research should be observed in accordance with a consistent moral code. The moral code of Good Clinical Practice (GCP) was developed in order to rule out inconsistencies. The principal tenets are that clinical trials should be good science, verifiable, monitored, well documented, and that they comply with the highest ethical standards. The principles of GCP are the protection of the rights of human subjects, integrity and reproducibility of data, and transparency of conduct.
Jurisprudence Thinking on Rights and Interests Protection of Chinese Human Subjects of Drug Clinical Research

Shao Rong,Zhang Yue,Wei Wei

DOI: https://doi.org/10.16153/j.1002-7777.2011.11.023

2011-01-01

Abstract:Objective To discuss the problem of protecting human subjects of drug clinical research.Methods Analyzed the vulnerable position of human subjects of drug clinical research,and then discussed the necessity to protect their rights and interests and theory base from a jurisprudence perspective.Results and Conclusion GCP provided human subjects some rights,giving them protection measures.It was not only the objective needs for achieving substantive equality but also an effective way to protect their interests.But GCP had many defects which should be changed in the revision of legal.
Problems and Countermeasures for the Ethical Review on the Drug Clinical Trials in China

Yan Jiangying,He Jishan,Zhang Yangde

DOI: https://doi.org/10.3969/j.issn.1002-7777.2012.04.010

2012-01-01

Abstract:Objective To promote the standardization of the ethical review procedure.Methods Through literature review,we summarized there are the problems of ethical review on the drug clinical trials in China and then provided the countermeasures.Results Compared with the European countries,the United States and other developed countries,the ethical review on the drug clinical trials in China started in a later time and was less perfect,there are some problems,such as lacking of scientific review on the study protocol,non-standardization of the informed consent procedure,inadequate training,unsound compensation mechanism for the subjects and so on.Conclusion In order to promote the solution of the above issues,countermeasures of improving the management system for the clinical trials,strengthening the supervision and management of the ethics committees at all levels,making the study protocol design of drug clinical trials scientificity,standardization of the informed consent procedure,developing a reasonable compensation mechanism,and carrying out special training for the ethics committees should be taken.
The Conflicts and Prevention Strategies in the Ethical Review of International Multi-center Trials of Drugs

Dong LI,Zhen-xing SU

DOI: https://doi.org/10.3969/j.issn.1002-0772.2014.13.008

2014-01-01

Abstract:International multi-center clinical trials of drugs ,including both pre-clinical trials of new drugs and further study , are expected to confirm or reveal the effects of the drug ,adverse reactions ,absorption ,distribution ,metabolism and excretion .With the increasing of international multi-center clinical trials of drugs ,the number of ethical conflicts in ethical review also increases apparently ,mainly in ethical standards ,the interests of all parties involved in the tests ,the quality differences ,the conflicts between localization and international ,test methods and ethical principles .In this regard ,we should enhance the quality and ability of central ethics committee ,pay attention to the coordination of the ethics committee interest ,and strengthen effective communication between ethics committees .
Clinical Trials in China: Protection of Subjects’ Rights and Interests

Y Lu

DOI: https://doi.org/10.1086/jce200415106

2004-01-01

Abstract:Previous articleNext article No AccessClinical Trials in China: Protection of Subjects' Rights and InterestsLü YuanLü YuanFirst Affiliated Hospital of Beijing University Search for more articles by this author PDFPDF PLUS Add to favoritesDownload CitationTrack CitationsPermissionsReprints Share onFacebookTwitterLinkedInRedditEmail SectionsMoreDetailsFiguresReferencesCited by Volume 15, Number 1Spring 2004 Published on behalf of the MacLean Center for Clinical Medical Ethics Article DOIhttps://doi.org/10.1086/JCE200415106 © 2004 The University of Chicago. All rights reserved.PDF download Crossref reports no articles citing this article.
From Bench to Bedside: A Review of Clinical Trials in Drug Discovery and Development

Tianyang Wang,Ming Liu,Benji Peng,Xinyuan Song,Charles Zhang,Xintian Sun,Qian Niu,Junyu Liu,Silin Chen,Keyu Chen,Ming Li,Pohsun Feng,Ziqian Bi,Yunze Wang,Yichao Zhang,Cheng Fei,Lawrence KQ Yan

2024-12-19

Abstract:Clinical trials are an indispensable part of the drug development process, bridging the gap between basic research and clinical application. During the development of new drugs, clinical trials are used not only to evaluate the safety and efficacy of the drug but also to explore its dosage, treatment regimens, and potential side effects. This review discusses the various stages of clinical trials, including Phase I (safety assessment), Phase II (preliminary efficacy evaluation), Phase III (large-scale validation), and Phase IV (post-marketing surveillance), highlighting the characteristics of each phase and their interrelationships. Additionally, the paper addresses the major challenges encountered in clinical trials, such as ethical issues, subject recruitment difficulties, diversity and representativeness concerns, and proposes strategies for overcoming these challenges. With the advancement of technology, innovative technologies such as artificial intelligence, big data, and digitalization are gradually transforming clinical trial design and implementation, improving trial efficiency and data quality. The article also looks forward to the future of clinical trials, particularly the impact of emerging therapies such as gene therapy and immunotherapy on trial design, as well as the importance of regulatory reforms and global collaboration. In conclusion, the core role of clinical trials in drug development will continue to drive the progress of innovative drug development and clinical treatment.

Computers and Society,Computation and Language
Ethical Reflection on Imaging Trials in Clinical Practice

YIN Hong,ZHANG Jian,HUAN Yi,XU Jun-qing,GE Ya-li,CHANG Ying-juan

DOI: https://doi.org/10.3969/j.issn.1001-8565.2007.02.036

2007-01-01

Abstract:This article introduces ethical problems emerging in the imaging trials in clinical practice,and stresses the importance of protecting the privacy of volunteers and patients,and their legal rights of informed consent.This article also stresses the importance of the respect for the basic human right of volunteers and patients,and puts forward some countermeasures to promote the efficiency and reasonable supervision system in the clinical trials.Last but not least,it also emphasizes the significance of a personalized-style of care for volunteers and patients.
Review of current controversial issues in clinical trials

Shein-Chung Chow,Susan S Chow,Annpey Pong

DOI: https://doi.org/10.1136/gpsych-2021-100540

2021-10-01

General Psychiatry

Abstract:In clinical development, adequate and well-controlled randomised clinical trials are usually conducted to evaluate the safety and efficacy of test treatment under investigation. The purpose is to ensure that there is an accurate and reliable assessment of test treatment under study. In practice, however, some controversial issues inevitably appear despite the compliance of good clinical practice. These debatable issues include, but are not limited to, (1) appropriateness of hypotheses for clinical investigation, (2) feasibility of power calculation for sample size requirement, (3) integrity of randomisation/blinding, (4) strategy for clinical endpoint selection, (5) demonstrating effectiveness or ineffectiveness, (6) impact of protocol amendments and (7) independence of independent data monitoring committee. In this article, these controversial issues are discussed. The impact of these issues in evaluating the safety and efficacy of the test treatment under investigation is also assessed. Recommendations regarding possible resolutions to these issues are provided whenever possible.
Ethical analysis in clinical research and experiment

赵菁,乔波,胡大一,丁荣晶,苟建军,张红,李中琳,胡凯

DOI: https://doi.org/10.3760/cma.j.issn.1006-1924.2015.04.008

2015-01-01

Abstract:The development of medical science and progress cannot do without clinical research,clinical research is mainly accomplished by clinical experiments with human subjects,medical workers engaged in clinical research and clinical trials,always ethical problems through scientific research and test.This article analysis specific case from the ethics committee to review the project from 2013 February to 2014 September in the First Affiliated Hospital of Zhengzhou University,fully illustrated the application of a good grasp of medical ethics in clinical scientific research,scientific research and medical workers in medical ethics is used in scientific research and experiment,standardize the medical behavior and the guarantee of scientific objectivity and authenticity of the powerful guarantee.

Thinking on Ethics and Science Principle in Clinical Drug Trials

Protection of Human Rights in Clinical Trials

Thinking on ethical principle in bioequivalence studies

On the Ethical Problem in Drug Clinical Trials

Ethical principles for clinical research

Development and Problems of Medical Ethics in Clinical Drug Trials

Main principles of designing clinical trial of drugs

Development and Problems of Medical Ethics in Foreign Clinical Drug Trials

Challenges to Ethics Committee and Investigators of Protecting the Rights of Subjects in Clinical Trials

The Ethical Protection for Participants of Vulnerable Groups in Clinical Trials

Ethical Principles of Clinical and Translational Research

Specialty and Related Medical Ethical Issues in Clinical Trials of Anticancer Drugs

Good clinical practice, a transparent way of life. A review

Jurisprudence Thinking on Rights and Interests Protection of Chinese Human Subjects of Drug Clinical Research

Problems and Countermeasures for the Ethical Review on the Drug Clinical Trials in China

The Conflicts and Prevention Strategies in the Ethical Review of International Multi-center Trials of Drugs

Clinical Trials in China: Protection of Subjects’ Rights and Interests

From Bench to Bedside: A Review of Clinical Trials in Drug Discovery and Development

Ethical Reflection on Imaging Trials in Clinical Practice

Review of current controversial issues in clinical trials

Ethical analysis in clinical research and experiment